BRIEF published on 05/26/2025 at 08:47, 1 year 4 months ago Guerbet revises its Board of Directors Board Of Directors Independent Director Appointment Guerbet Mandate
PRESS RELEASE published on 05/26/2025 at 08:42, 1 year 4 months ago Guerbet : Changes in the composition of the Guerbet board of directors. Guerbet reorganizes Board of Directors with appointment and reappointment of independent directors and reduction of terms to 4 years, following the AGM decisions Board Of Directors Reorganization AGM Guerbet Independent Directors
BRIEF published on 04/11/2025 at 17:50, 1 year 6 months ago GUERBET: Update of share capital and voting rights Share Capital Voting Rights Treasury Shares Guerbet AMF Regulations
BRIEF published on 04/03/2025 at 15:25, 1 year 6 months ago Provision of the 2024 Universal Registration Document by Guerbet AMF Financial Report Guerbet Medical Imaging Registration Document
BRIEF published on 02/21/2025 at 17:50, 1 year 8 months ago Guerbet: Update of shares and voting rights as of January 31, 2025 Voting Rights Actions AMF Transparency Guerbet
BRIEF published on 02/03/2025 at 12:05, 1 year 8 months ago Guerbet Appoints NATIXIS ODDO BHF for Liquidity Contract Euronext Paris Liquidity Contract NATIXIS ODDO BHF Guerbet Financial Markets
PRESS RELEASE published on 02/03/2025 at 12:00, 1 year 8 months ago GUERBET : Implementation of a Liquidity Contract with NATIXIS ODDO BHF Guerbet ends current liquidity contract and appoints NATIXIS and ODDO BHF for a new liquidity contract compliant with AMF guidelines, aiming to improve shares trading on Euronext Paris market Liquidity Contract Natixis ODDO BHF Guerbet Shares Trading
BRIEF published on 01/31/2025 at 17:50, 1 year 8 months ago Guerbet Announces 2025 Financial Agenda Financial Results Financial Agenda Guerbet Medical Imaging 2025
PRESS RELEASE published on 01/31/2025 at 17:45, 1 year 8 months ago Correction: GUERBET : Financial agenda for 2025 Guerbet announces its financial agenda for 2025 including revenue updates and shareholder meeting schedule Financial Agenda Guerbet Shareholder Meeting 2025 Revenue Updates
BRIEF published on 10/30/2024 at 15:57, 1 year 11 months ago New figures on Guerbet shares and voting rights in September 2024 Voting Rights Capital Actions AMF Guerbet
Published on 10/22/2026 at 16:00, 4 hours 42 minutes ago Future Fuels Announces Closing of Brokered Offering for Gross Proceeds of C$6.6 Million
Published on 10/22/2026 at 14:30, 6 hours 12 minutes ago Unusual Machines Receives $16.9 Million Purchase Order from Powerus for American-Made Drone Components
Published on 10/22/2026 at 14:00, 6 hours 42 minutes ago Jericho Energy Ventures Amends Investor Relations Agreement with Orange Group Advisors
Published on 10/22/2026 at 14:00, 6 hours 42 minutes ago Viemed Healthcare Announces Third Quarter 2026 Earnings Conference Call Details
Published on 10/22/2026 at 13:45, 6 hours 57 minutes ago Karbon-X (OTCQB:KARX) Accelerates High-Margin Transformation in Q1 FY2027: Gross Margin Expands to 32%, Operating Cash Burn Drops 55%, and Deferred Revenue Reaches $4.3 Million
Published on 10/22/2026 at 20:00, 42 minutes ago Exchange offer for Eleving Group 2023/2028 bonds (ISIN DE000A3LL7M4) completed
Published on 10/22/2026 at 18:45, 1 hour 57 minutes ago Swedish Export Credit Corporation (SEK): Europe's defence build-up opens opportunities for Swedish companies in Germany
Published on 10/22/2026 at 18:12, 2 hours 30 minutes ago LION E-Mobility AG: CEO Dr. Joachim Damasky to retire at the end of January 2027
Published on 10/22/2026 at 18:10, 2 hours 32 minutes ago EQS-Adhoc: LION E-Mobility AG: CEO Dr. Joachim Damasky to retire at the end of January 2027
Published on 10/22/2026 at 18:03, 2 hours 38 minutes ago Voltatron Strengthens Financial Foundation for Further Growth by Securing €14 Million Financing Package
Published on 10/22/2026 at 18:00, 2 hours 42 minutes ago THERMADOR GROUPE : Completion of the share buy-back programme launched in August
Published on 10/22/2026 at 18:00, 2 hours 42 minutes ago bioMérieux receives Dual 510(k) Clearance and CLIA Waiver from the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel to Advance Women’s Health with Rapid Molecular Diagnostics
Published on 10/22/2026 at 18:00, 2 hours 42 minutes ago H1 2026: marked improvement in operating results
Published on 10/22/2026 at 17:47, 2 hours 55 minutes ago Aéroports de Paris SA - 2026 9-month revenue
Published on 10/22/2026 at 17:45, 2 hours 57 minutes ago Third-quarter 2026 : Accor upgrades its EBITDA guidance
